Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × niraparib × Other solid neoplasm × Clear all

Phase

Status

Completed 4 Unknown 2 Terminated 2 Recruiting 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 10 Genitourinary 8 Breast 5 CNS 4 Tumor-Agnostic 3 Gastrointestinal 3 Thoracic 2 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Endocrine 1

Conditions

Interventions

pembrolizumab 23 Nivolumab 10 Cyclophosphamide 9 Pemetrexed 8 atezolizumab 7 Specimen Handling 7 Cisplatin 7 Carboplatin 6 Biopsy 6 Radiotherapy 5 Ipilimumab 5 Injections 5 tislelizumab 4 fludarabine 4 Proton Therapy 4 Platinum 4 Paclitaxel 4 Drug Therapy 4 1,2-diaminocyclohexaneplatinum II citrate 4 toripalimab 3 spartalizumab 3 sotorasib 3 durvalumab 3 Vincristine 3 Trastuzumab 3 Radiation 3 Gemcitabine 3 Docetaxel 3 Cetuximab 3 Bevacizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡